fda tirzepatide update today ban on compounded tirzepatide: Switch to name brand medications FDA Affirms Decision on Tirzepatide

Always consult a qualified healthcare provider before beginning any new dietary supplement, particularly if you have a pre-existing health condition or are taking prescribed medication

300 Wang, Y

eligibility is determined by the evaluating clinician

2025 Jun 5;16(3):568-579

Your clinician may suggest switching from injected semaglutide to oral formulation, exploring the Microdose GLP-1 Protocol ($129/mo), or considering a dual-compound approach like GLP-Squared Injection (semaglutide plus tirzepatide at $249/mo), which some patients tolerate better gastrointestinally

Rusin D, Vahl Becirovic L, Lyszczarz G, Krueger M, Benmamar-Badel A, Vad Mathiesen C, Sigurardttir Schith E, Lykke Lambertsen K, Wlodarczyk A (2024) Microglia-derived insulin-like growth factor 1 is critical for neurodevelopment